| Literature DB >> 26407300 |
Nelesh P Govender1, Tsidiso G Maphanga2, Thokozile G Zulu2, Jaymati Patel2, Sibongile Walaza1, Charlene Jacobs2, Joy I Ebonwu3, Sindile Ntuli2, Serisha D Naicker2, Juno Thomas1.
Abstract
BACKGROUND: The largest outbreak of sporotrichosis occurred between 1938 and 1947 in the gold mines of Witwatersrand in South Africa. Here, we describe an outbreak of lymphocutaneous sporotrichosis that was investigated in a South African gold mine in 2011.Entities:
Mesh:
Substances:
Year: 2015 PMID: 26407300 PMCID: PMC4583532 DOI: 10.1371/journal.pntd.0004096
Source DB: PubMed Journal: PLoS Negl Trop Dis ISSN: 1935-2727
Fig 1Flowchart of cases of confirmed and probable sporotrichosis detected at a reopened section of a gold mine by month, Barberton, 2009–2011, n = 17.
Fig 2Epidemic curve with cases of confirmed and probable sporotrichosis detected at a reopened section of a gold mine by month, Barberton, 2009–2011, n = 17.
Comparison of miners with and without confirmed or probable sporotrichosis at a reopened section of a gold mine, Barberton, n = 81.
| Characteristic | Miners with confirmed or probable sporotrichosis (n = 17) | Miners without confirmed or probable sporotrichosis (n = 64) | p-value | Unadjusted odds ratio (95% CI) | p-value | Adjusted odds ratio (95% CI) | p-value | |
|---|---|---|---|---|---|---|---|---|
| Median age, IQR (years) | 34 (25–40) | 34 (25–48) | ||||||
| Age category (years) | 20–24 | 1/17 (6) | 3/64 (5) | 0.61 | Reference | 0.67 | ||
| 25–29 | 5/17 (29) | 18/64 (28) | 0.83 (0.07–9.86) | |||||
| 30–34 | 4/17 (23) | 15/64 (23) | 0.80 (0.06–9.92) | |||||
| 35–39 | 3/17 (18) | 14/64 (22) | 0.64 (0.05–8.52) | |||||
| 40–44 | 1/17 (6) | 8/64 (12) | 0.38 (0.17–8.10) | |||||
| 45–49 | 3/17 (18) | 3/64 (5) | 3.00 (0.19–47.96) | |||||
| 50–54 | 0/17 (0) | 3/64 (5) | Unspecified | |||||
| Previous work at other mines | No | 10/17 (59) | 46/64 (72) | 0.30 | Reference | 0.31 | ||
| Yes | 7/17 (41) | 18/64 (28) | 1.78 (0.59–5.42) | |||||
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| ||||
| Occupational category | Supervisor | 1/17 (6) | 13/64 (20) | 0.26 | Reference | 0.21 | ||
| Specialist worker | 1/17 (6) | 7/64 (11) | 1.85 (0.10–34.43) | |||||
| General worker | 15/17 (88) | 44/64 (69) | 4.43 (0.53–36.80) | |||||
| Hours worked underground per day | ≤ 5 hours | 1/16 (6) | 7/61 (12) | 0.54 | Reference | 0.52 | ||
| > 5 hours | 15/16 (94) | 54/61 (88) | 1.95 (0.22–17.06) | |||||
| Current mine level | Surface | 1/16 (6) | 1/51 (2) | 0.17 | Reference | 0.90 | ||
| All levels | 1/16 (6) | 7/51 (13) | 0.14 (0.04–4.61) | |||||
| Level 14 | 2/16 (13) | 8/51 (15) | 0.25 (0.01–5.98) | |||||
| Level 16 | 4/16 (24) | 10/51 (19) | 0.40 (0.19–8.07) | |||||
| Level 30 | 0/16 (0) | 7/51 (13) | Unspecified | |||||
| Level 32 | 2/16 (13) | 0/51 (0) | Unspecified | |||||
| Level 34 | 4/16 (25) | 13/51 (25) | 0.31 ((0.02–6.11) | |||||
| Level 38 | 2/16 (13) | 7/51 (13) | 0.29 (0.12–6.91) | |||||
| HIV-infected | No | 5/8 (63) | 26/34 (76) | 0.42 | Reference | 0.43 | ||
| Yes | 3/8 (37) | 8/34 (24) | 1.95 (0.38–10.01) | |||||
| Other underlying diseases | No | 16/17 (94) | 59/64 (92) | 0.79 | Reference | 0.78 | ||
| Yes | 1/17 (6) | 5/64 (8) | 0.74 (0.08–6.76) | |||||
| Reported cuts or scratches on exposed areas | No | 7/17 (41) | 32/64 (50) | 0.52 | Reference | 0.51 | ||
| Yes | 10/17 (59) | 32/64 (50) | 1.42 (0.48–4.21) | |||||
| Reported wood splinter injury or skin contact with wood | No | 4/17 (24) | 10/64 (16) | 0.44 | Reference | 0.45 | ||
| Yes | 13/17 (76) | 54/64 (84) | 0.60 (0.16–2.23) | |||||
| Reported skin contact with soil | No | 1/17 (6) | 9/64 (14) | 0.36 | Reference | 0.33 | ||
| Yes | 16/17 (94) | 55/64 (86) | 2.62 (0.31–22.25) | |||||
| Frequent use of personal protective equipment | No | 1/17 (6) | 6/64 (9) | 0.65 | Reference | 0.63 | ||
| Yes | 16/17 (94) | 58/64 (91) | 1.66 (0.19–14.76) | |||||
| Shower immediately after shift | No | 0/17 (0) | 2/64 (3) | 0.46 | Unspecified | |||
| Yes | 17/17 (100) | 62/64 (97) | ||||||
| Launder overalls more than once per week | No | 0/15 (0) | 3/61 (5) | 0.38 | Unspecified | |||
| Yes | 15/15 (100) | 58/61 (95) | ||||||
| Reported outdoor activities outside of work | No | 4/17 (24) | 34/64 (53) | 0.03 | Reference | 0.03 | Reference | 0.06 |
| Yes | 13/17 (76) | 30/64 (47) | 3.68 (1.08–12.51) | 3.4 (0.96–12.00) |
*Denominators are less than column total because of missing data;
**Previous or current tuberculosis, malignancy, diabetes or chronic lung disease;
†Reported use of gloves, boots, masks, goggles, helmets and overalls as “always” or “most of the time”;
††Not included in the multivariable model.
Comparison of miners with confirmed and probable sporotrichosis at a reopened section of a gold mine, Barberton, n = 17.
| Characteristic | Cases of confirmed sporotrichosis | Cases of probable sporotrichosis | |
|---|---|---|---|
| Location of skin lesions | Head and neck | 1/10 (10) | 1/7 (14) |
| Upper limb/s | 8/10 (80) | 6/7 (86) | |
| Lower limb/s | 1/10 (10) | 0/7 (0) | |
| Trunk | 0/10 (0) | 0/7 (0) | |
| Type of skin lesion | Nodule | 0/10 (0) | 1/7 (14) |
| Ulcer | 1/10 (10) | 4/7 (57) | |
| Nodule and ulcer | 7/10 (70) | 1/7 (14) | |
| Nodule, ulcer, draining pus | 1/10 (10) | 0/7 (0) | |
| Ulcer and verrucous lesion | 1/10 (10) | 0/7 (0) | |
| Ulcer and plaque | 0/10 (0) | 1/7 (14) | |
| Palpable lymphatic vessels | 3/10 (30) | 0/7 (0) | |
| Local lymphadenopathy | 5/10 (50) | 1/7 (14) | |
| Active skin lesion (vs. healed) | 10/10 (100) | 3/7 (43) | |
| Median duration of skin lesions, IQR (days) | 49 (21–61) | 181 (123–241) | |
| Multiple skin lesions | 10/10 (100) | 6/7 (86) | |
| Number of skin lesions | ≤ 5 lesions | 10/10 (100) | 4/7 (57) |
| > 5 lesions | 0/0 (0) | 3/7 (43) | |
| On itraconazole treatment at the time of clinical examination | 10/10 (100) | 4/7 (57) | |
| Median time from lesion appearance to initiation of itraconazole treatment, IQR (days) | 35 (8–51) | 153 (102–219) | |
| Reported cut or scratch before lesion | 3/10 (30) | 2/7 (29) |
*None of the patients had clinical evidence of disseminated disease.
Fig 3A patient with probable sporotrichosis of the upper limb with a chain of healed lesions in a classic lymphocutaneous distribution.
Minimum inhibitory concentrations for the yeast phase of Sporothrix schenckii complex isolates, n = 13.
| Isolate number | Source | Species-level identification | Minimum inhibitory concentration (mg/L): | |||||||
|---|---|---|---|---|---|---|---|---|---|---|
| AMB BMD | AMB Etest | VRC BMD | VRC Etest | POS BMD | POS Etest | ITC BMD | ITC Etest | |||
| 38.1 | Clinical |
| 4 | >32 | 0.25 | 2 | 0.5 | 0.75 | 0.5 | 0.75 |
| 41.1 | Clinical |
| >8 | >32 | 0.5 | 2 | 0.5 | 0.25 | 0.5 | 0.75 |
| 53 | Clinical |
| 1 | >32 | 0.008 | 2 | 0.008 | 0.19 | 0.015 | 2 |
| 55 | Clinical |
| Contaminated | |||||||
| 57 | Clinical |
| >8 | 1 | 0.25 | 1.5 | 0.5 | 0.094 | 0.25 | 0.5 |
| 60 | Clinical |
| >8 | >32 | 0.5 | 4 | 0.5 | 0.19 | 0.5 | 4 |
| 82 | Clinical |
| >8 | >32 | 0.5 | 2 | 0.5 | 0.5 | 0.5 | 4 |
| 85 | Clinical |
| >8 | 4 | 1 | 4 | 0.25 | 0.25 | 0.12 | 0.019 |
| 1 | Environmental |
| >8 | >32 | >8 | >32 | >8 | >32 | >16 | >32 |
| 7 | Environmental |
| >8 | >32 | 4 | >8 | >8 | >32 | >16 | >32 |
| 8 | Environmental |
| 2 | >32 | 0.25 | 1.5 | 0.5 | >32 | 0.5 | >32 |
| 10 | Environmental |
| >8 | >32 | >8 | >32 | >8 | >32 | >16 | >32 |
| 12 | Environmental |
| >8 | >32 | 4 | >32 | >8 | >32 | >16 | >32 |
*Species-level identity was determined by sequencing of the nuclear calmodulin gene;
†multiple isolates from the same patient were not tested (i.e. isolates 38.2, 41.2 and 41.3);
abbreviations: AMB: amphotericin B; VRC: voriconazole; POS: posaconazole; ITC: itraconazole; BMD: broth microdilution test.
Fig 4Phylogenetic analysis of the partial calmodulin gene sequences from 10 clinical outbreak isolates, 5 environmental outbreak isolates, 9 unrelated clinical strains and 10 reference strains.